Clinical Trial Type: Kidney

Name of this trial: LITESPARK-033 What type of cancer is this for?  Advanced Renal/Kidney Cancer Who is this trial for?  People with recurrent renal cell cancer following adjuvant therapy with anti-PD-1/L1 Therapy. What biomarkers are involved? N/A What is the National Clinical Trial #? NCT07227402  Brief summary of this trial:  Randomized, open-label study of Belzutifan + Zanzalintinib vs. Cabozantinib. Need to